Cargando…
Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma
Glioblastoma (GBM) is the most common type of malignant tumor of the central nervous system. The prognosis of patients with GBM is very poor, with a survival time of ~15 months. GBM is highly heterogeneous and highly aggressive. Surgical removal of intracranial tumors does provide a good advantage f...
Autores principales: | Zhou, Lingqi, Tang, Hai, Wang, Fang, Chen, Lizhi, Ou, Shanshan, Wu, Tong, Xu, Jie, Guo, Kaihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172372/ https://www.ncbi.nlm.nih.gov/pubmed/30132538 http://dx.doi.org/10.3892/mmr.2018.9411 |
Ejemplares similares
-
Cyclovirobuxine D inhibits cell proliferation and migration and induces apoptosis in human glioblastoma multiforme and low-grade glioma
por: Zhou, Lingqi, et al.
Publicado: (2020) -
Lycopene alleviates oxidative stress via the PI3K/Akt/Nrf2pathway in a cell model of Alzheimer’s disease
por: Fang, Yinchao, et al.
Publicado: (2020) -
Studies on APP metabolism related to age-associated mitochondrial dysfunction in APP/PS1 transgenic mice
por: Chen, Lizhi, et al.
Publicado: (2019) -
Platelets transport β-amyloid from the peripheral blood into the brain by destroying the blood-brain barrier to accelerate the process of Alzheimer's disease in mouse models
por: Wu, Tong, et al.
Publicado: (2021) -
AEBP1 as a potential immune-related prognostic biomarker in glioblastoma: a bioinformatic analyses
por: Liu, Mingjian, et al.
Publicado: (2021)